← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2009Last known activity
Sep 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (4)
- NCT07083765OfficialPhase 3Sep 1, 2025
- NCT03929718Lead sponsorEarly Phase 1Apr 24, 2019
- NCT03929718Overall official - principal investigatorEarly Phase 1Apr 24, 2019
- NCT01030328Lead sponsorPhase 3Nov 1, 2009
Details
- Last known activity
- Sep 1, 2025